Header Logo

Connection

Julie Schneider to Middle Aged

Back to Details
This is a "connection" page, showing publications Julie Schneider has written about Middle Aged.
Julie Schneider
Connection Strength
0.740
Middle Aged
  1. A novel SNCA E83Q mutation in a case of dementia with Lewy bodies and atypical frontotemporal lobar degeneration. Neuropathology. 2020 Dec; 40(6):620-626.
    View in: PubMed
    Score: 0.070
  2. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain. 2019 06 01; 142(6):1503-1527.
    View in: PubMed
    Score: 0.065
  3. Temporal course and pathologic basis of unawareness of memory loss in dementia. Neurology. 2015 Sep 15; 85(11):984-91.
    View in: PubMed
    Score: 0.050
  4. TDP-43 pathology, cognitive decline, and dementia in old age. JAMA Neurol. 2013 Nov; 70(11):1418-24.
    View in: PubMed
    Score: 0.044
  5. The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study. Lancet Neurol. 2022 08; 21(8):714-725.
    View in: PubMed
    Score: 0.020
  6. Improved detection of substantia nigra pathology in Alzheimer's disease. J Histochem Cytochem. 2002 Jan; 50(1):99-106.
    View in: PubMed
    Score: 0.019
  7. Genome-wide association study and functional validation implicates JADE1 in tauopathy. Acta Neuropathol. 2022 01; 143(1):33-53.
    View in: PubMed
    Score: 0.019
  8. To what degree is late life cognitive decline driven by age-related neuropathologies? Brain. 2021 08 17; 144(7):2166-2175.
    View in: PubMed
    Score: 0.019
  9. A Genetic Study of Cerebral Atherosclerosis Reveals Novel Associations with NTNG1 and CNOT3. Genes (Basel). 2021 05 26; 12(6).
    View in: PubMed
    Score: 0.019
  10. Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related Tauopathy. J Neuropathol Exp Neurol. 2021 01 20; 80(2):102-111.
    View in: PubMed
    Score: 0.018
  11. Vitamin D and Vitamin K Concentrations in Human Brain Tissue Are Influenced by Freezer Storage Time: The Memory and Aging Project. J Nutr. 2021 01 04; 151(1):104-108.
    View in: PubMed
    Score: 0.018
  12. B and T Lymphocyte Densities Remain Stable With Age in Human Cortex. ASN Neuro. 2021 Jan-Dec; 13:17590914211018117.
    View in: PubMed
    Score: 0.018
  13. Cross-Species Analyses Identify Dlgap2 as a Regulator of Age-Related Cognitive Decline and Alzheimer's Dementia. Cell Rep. 2020 09 01; 32(9):108091.
    View in: PubMed
    Score: 0.018
  14. Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nat Commun. 2020 02 03; 11(1):667.
    View in: PubMed
    Score: 0.017
  15. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's disease. Nat Med. 2020 01; 26(1):131-142.
    View in: PubMed
    Score: 0.017
  16. Brain Bromine Levels Associated with Alzheimer's Disease Neuropathology. J Alzheimers Dis. 2020; 73(1):327-332.
    View in: PubMed
    Score: 0.017
  17. Seasonal plasticity of cognition and related biological measures in adults with and without Alzheimer disease: Analysis of multiple cohorts. PLoS Med. 2018 09; 15(9):e1002647.
    View in: PubMed
    Score: 0.015
  18. A transcriptomic atlas of aged human microglia. Nat Commun. 2018 02 07; 9(1):539.
    View in: PubMed
    Score: 0.015
  19. Loss of Munc18-1 long splice variant in GABAergic terminals is associated with cognitive decline and increased risk of dementia in a community sample. Mol Neurodegener. 2015 Dec 02; 10:65.
    View in: PubMed
    Score: 0.013
  20. Suprachiasmatic neuron numbers and rest-activity circadian rhythms in older humans. Ann Neurol. 2015 Aug; 78(2):317-22.
    View in: PubMed
    Score: 0.012
  21. a-Synuclein pathology accumulates in sacral spinal visceral sensory pathways. Ann Neurol. 2015 Jul; 78(1):142-9.
    View in: PubMed
    Score: 0.012
  22. Residual decline in cognition after adjustment for common neuropathologic conditions. Neuropsychology. 2015 May; 29(3):335-43.
    View in: PubMed
    Score: 0.012
  23. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. JAMA Neurol. 2014 Nov; 71(11):1394-404.
    View in: PubMed
    Score: 0.012
  24. Theoretical impact of Florbetapir (18F) amyloid imaging on diagnosis of alzheimer dementia and detection of preclinical cortical amyloid. J Neuropathol Exp Neurol. 2014 Oct; 73(10):948-53.
    View in: PubMed
    Score: 0.012
  25. Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nat Neurosci. 2014 Sep; 17(9):1156-63.
    View in: PubMed
    Score: 0.012
  26. Clinical-pathologic study of depressive symptoms and cognitive decline in old age. Neurology. 2014 Aug 19; 83(8):702-9.
    View in: PubMed
    Score: 0.012
  27. A novel GRN mutation (GRN c.708+6_+9delTGAG) in frontotemporal lobar degeneration with TDP-43-positive inclusions: clinicopathologic report of 6 cases. J Neuropathol Exp Neurol. 2014 May; 73(5):467-73.
    View in: PubMed
    Score: 0.011
  28. Neuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlates. J Neuropathol Exp Neurol. 2014 Jan; 73(1):72-80.
    View in: PubMed
    Score: 0.011
  29. Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women. Neurology. 2014 Jan 21; 82(3):222-9.
    View in: PubMed
    Score: 0.011
  30. A 2-process model for neuropathology of Alzheimer's disease. Neurobiol Aging. 2014 Feb; 35(2):301-8.
    View in: PubMed
    Score: 0.011
  31. Genetic susceptibility for Alzheimer disease neuritic plaque pathology. JAMA Neurol. 2013 Sep 01; 70(9):1150-7.
    View in: PubMed
    Score: 0.011
  32. The PSEN1, p.E318G variant increases the risk of Alzheimer's disease in APOE-e4 carriers. PLoS Genet. 2013; 9(8):e1003685.
    View in: PubMed
    Score: 0.011
  33. Life-span cognitive activity, neuropathologic burden, and cognitive aging. Neurology. 2013 Jul 23; 81(4):314-21.
    View in: PubMed
    Score: 0.011
  34. CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology. Nat Neurosci. 2013 Jul; 16(7):848-50.
    View in: PubMed
    Score: 0.011
  35. Brain amyloid-? oligomers in ageing and Alzheimer's disease. Brain. 2013 May; 136(Pt 5):1383-98.
    View in: PubMed
    Score: 0.011
  36. Neural reserve, neuronal density in the locus ceruleus, and cognitive decline. Neurology. 2013 Mar 26; 80(13):1202-8.
    View in: PubMed
    Score: 0.011
  37. APOE e4 increases risk for dementia in pure synucleinopathies. JAMA Neurol. 2013 Feb; 70(2):223-8.
    View in: PubMed
    Score: 0.010
  38. GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology. Neurology. 2012 Nov 06; 79(19):1944-50.
    View in: PubMed
    Score: 0.010
  39. Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-? plaques: a prospective cohort study. Lancet Neurol. 2012 Aug; 11(8):669-78.
    View in: PubMed
    Score: 0.010
  40. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest. 2012 Apr; 122(4):1316-38.
    View in: PubMed
    Score: 0.010
  41. CR1 is associated with amyloid plaque burden and age-related cognitive decline. Ann Neurol. 2011 Mar; 69(3):560-9.
    View in: PubMed
    Score: 0.009
  42. Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA. 2011 Jan 19; 305(3):275-83.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.